1.33% -0.001

Hepion Pharmaceuticals Inc (HEPA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile

Hepion Pharmaceuticals Inc

Healthcare (1081)

Biotechnology (607)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HEPA's Discussions on Twitter

Compare HEPA vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HEPA Hepion Pharmaceuticals Inc	0.074	0	0	-2.98M	-1.71M	-0.259
VRTX Vertex Pharmaceuticals Inc	552.85	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	833.56	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,019.49	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	158.83	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.38	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-07-20	Fortgesetzt	ROTH Capital	Buy

Hepion Pharmaceuticals Inc Aktie (HEPA) Neueste Nachrichten

Finanzdaten der Hepion Pharmaceuticals Inc-Aktie (HEPA)

Hepion Pharmaceuticals Inc (HEPA)

Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile

Compare HEPA vs VRTX, REGN, ARGX, MRNA, RVMD

Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades

Hepion Pharmaceuticals Inc Aktie (HEPA) Neueste Nachrichten

Hepion (HEPA) grants interim CEO 1.35M options at $0.08 - Stock Titan

Hepion chair granted 1.35M options at $0.08 | HEPA Insider Trading - Stock Titan

Hepion Pharmaceuticals (HEPA) gives VP 1.35M options at $0.08 - Stock Titan

Hepion (HEPA) director awarded 299K stock options - Stock Titan

Hepion Pharmaceuticals (HEPA) awards director 299K stock options - Stock Titan

Hepion Pharmaceuticals (HEPA) awards 299K options to director - Stock Titan

Hepion Pharmaceuticals Appoints James Liddy to Board of Directors - Minichart

Hepion appoints James Liddy to its board - TradingView

Hepion (NASDAQ: HEPA) COO locks in 2M warrants at $0.06 - Stock Titan

Hepion (HEPA) chairman-led group builds 26M-share stake - Stock Titan

Black Global 5 Llc Net Worth (2026) - GuruFocus

Wednesday’s insider buys and sells: Hepion insiders invest $800K By Investing.com - Investing.com Nigeria

Hepion Pharmaceuticals, Inc. Q2 2026: Revenue $0 Net loss $(1.25M), EPS $(0.08) — 10-Q Summary - TradingView

Hepion Pharmaceuticals director Stetz buys $25,000 in common stock By Investing.com - Investing.com Nigeria

Hepion Pharmaceuticals director Michael Purcell buys $100,000 in stock By Investing.com - Investing.com Australia

Hepion Pharmaceuticals director Stetz buys $25,000 in common stock - Investing.com

Hepion Pharmaceuticals interim CEO Gary Stetz buys $100,000 in stock - Investing.com

Hepion Pharmaceuticals interim CEO Gary Stetz buys $100,000 in stock By Investing.com - Investing.com South Africa

Hepion COO Sireesh Appajosyula buys $100,000 in common stock By Investing.com - Investing.com Nigeria

Hepion COO Sireesh Appajosyula buys $100,000 in common stock - Investing.com

Hepion Pharmaceuticals executive chairman LoPriore buys $500,000 in stock - Investing.com

Hepion Pharmaceuticals executive chairman LoPriore buys $500,000 in stock By Investing.com - Investing.com India

Hepion Pharmaceuticals (HEPA) director purchases 500K shares and 500K warrants - Stock Titan

Hepion Pharmaceuticals (NASDAQ: HEPA) director purchases 2M shares and 2M warrants - Stock Titan

Hepion Pharmaceuticals (HEPA) interim CEO Stetz buys 4M shares and warrants - Stock Titan

Hepion Pharmaceuticals (HEPA) chair LoPriore reports 20M-share and warrant purchases - Stock Titan

Hepion Pharmaceuticals director Michael Purcell buys $100,000 in stock - Investing.com

Hepion Pharmaceuticals (HEPA) holder reports 10M warrants and 10M shares - Stock Titan

Darin Feinstein Discloses Investment at Hepion Pharmaceuticals with 11.1% Stake - TradingView

Investor buys 10M Hepion Pharmaceuticals (HEPA) shares plus warrant - Stock Titan

Hepion Pharmaceuticals (HEPA) completes $3.06M exempt securities sale under Rule 506(b) - stocktitan.net

Hepion Pharmaceuticals Announces New Private Placement Financing - TipRanks

Hepion Pharmaceuticals, Inc. announced that it has received $3.055 million in funding - marketscreener.com

Hepion Pharmaceuticals, Inc. Revenue Breakdown – OTC:HEPA - TradingView

Hepion Pharmaceuticals, Inc. Revenue Breakdown – OTC:CTRVP - TradingView

Hepion Pharmaceuticals (HEPA) Proxy Filing Summary - Quartr

Hepion Pharmaceuticals (HEPA) Proxy filing Summary - Quartr

Hepion Pharmaceuticals (HEPA) Q4 2025 earnings summary - Quartr

Hepion Pharmaceuticals (HEPA) director Stetz submits initial insider Form 3 - Stock Titan

Hepion Pharmaceuticals (HEPA) director Danina Fisher files initial Form 3 - Stock Titan

Hepion Pharmaceuticals keeps the focus on its pipeline - AD HOC NEWS

Two new directors join Hepion Pharmaceuticals (OTC: HEPA) board - Stock Titan

Hepion Pharmaceuticals updates CRV431 liver program, shares follow biotech peers - Ad-hoc-news.de

Enterprise value to revenue forward of Hepion Pharmaceuticals, Inc. – OTC:HEPA - TradingView

Hepion Pharmaceuticals, Inc. Actuals & Estimates (OTC:HEPA) - TradingView

Enterprise value to EBIT forward of Hepion Pharmaceuticals, Inc. – OTC:CTRVP - TradingView

Price to book forward of Hepion Pharmaceuticals, Inc. – OTC:CTRVP - TradingView

Price to sales forward of Hepion Pharmaceuticals, Inc. – OTC:CTRVP - TradingView

Price to earnings forward of Hepion Pharmaceuticals, Inc. – OTC:CTRVP - TradingView

Hepion Pharmaceuticals Inc (HEPA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Hepion Pharmaceuticals Inc (HEPA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Finanzdaten der Hepion Pharmaceuticals Inc-Aktie (HEPA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie HEPA